Review



mouse interferon beta ifn β enzyme linked immunosorbent assay  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Elabscience Biotechnology mouse interferon beta ifn β enzyme linked immunosorbent assay
    Mouse Interferon Beta Ifn β Enzyme Linked Immunosorbent Assay, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 45 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse interferon beta ifn β enzyme linked immunosorbent assay/product/Elabscience Biotechnology
    Average 95 stars, based on 45 article reviews
    mouse interferon beta ifn β enzyme linked immunosorbent assay - by Bioz Stars, 2026-04
    95/100 stars

    Images



    Similar Products

    mouse ifn-beta quantikine elisa kit  (Bio-Techne corporation)
    99
    Bio-Techne corporation mouse ifn-beta quantikine elisa kit
    Mouse Ifn Beta Quantikine Elisa Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse ifn-beta quantikine elisa kit/product/Bio-Techne corporation
    Average 99 stars, based on 1 article reviews
    mouse ifn-beta quantikine elisa kit - by Bioz Stars, 2026-04
    99/100 stars
    		  Buy from Supplier
    mouse interferon beta ifn β enzyme linked immunosorbent assay  (Elabscience Biotechnology)
    95
    Elabscience Biotechnology mouse interferon beta ifn β enzyme linked immunosorbent assay
    Mouse Interferon Beta Ifn β Enzyme Linked Immunosorbent Assay, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse interferon beta ifn β enzyme linked immunosorbent assay/product/Elabscience Biotechnology
    Average 95 stars, based on 1 article reviews
    mouse interferon beta ifn β enzyme linked immunosorbent assay - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    mouse interferon β ifn β elisa kit  (Elabscience Biotechnology)
    95
    Elabscience Biotechnology mouse interferon β ifn β elisa kit
    In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and <t>(n)</t> <t>IFN-β</t> in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.
    Mouse Interferon β Ifn β Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse interferon β ifn β elisa kit/product/Elabscience Biotechnology
    Average 95 stars, based on 1 article reviews
    mouse interferon β ifn β elisa kit - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    mouse ifn β  (R&D Systems)
    95
    R&D Systems mouse ifn β
    In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and <t>(n)</t> <t>IFN-β</t> in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.
    Mouse Ifn β, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse ifn β/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    mouse ifn β - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    rd systems elisa kit  (R&D Systems)
    95
    R&D Systems rd systems elisa kit
    In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and <t>(n)</t> <t>IFN-β</t> in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.
    Rd Systems Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rd systems elisa kit/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    rd systems elisa kit - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    mouse ifn β  (Elabscience Biotechnology)
    95
    Elabscience Biotechnology mouse ifn β
    In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and <t>(n)</t> <t>IFN-β</t> in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.
    Mouse Ifn β, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse ifn β/product/Elabscience Biotechnology
    Average 95 stars, based on 1 article reviews
    mouse ifn β - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    ifn β ifnb elisa kit  (Cusabio)
    93
    Cusabio ifn β ifnb elisa kit
    In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and <t>(n)</t> <t>IFN-β</t> in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.
    Ifn β Ifnb Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ifn β ifnb elisa kit/product/Cusabio
    Average 93 stars, based on 1 article reviews
    ifn β ifnb elisa kit - by Bioz Stars, 2026-04
    93/100 stars
    		  Buy from Supplier
    e04945m  (Cusabio)
    93
    Cusabio e04945m
    In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and <t>(n)</t> <t>IFN-β</t> in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.
    E04945m, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e04945m/product/Cusabio
    Average 93 stars, based on 1 article reviews
    e04945m - by Bioz Stars, 2026-04
    93/100 stars
    		  Buy from Supplier
    ifnβ 8234 mb  (R&D Systems)
    95
    R&D Systems ifnβ 8234 mb
    In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and <t>(n)</t> <t>IFN-β</t> in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.
    Ifnβ 8234 Mb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ifnβ 8234 mb/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    ifnβ 8234 mb - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    mouse ifnβ duoset elisa kit  (R&D Systems)
    96
    R&D Systems mouse ifnβ duoset elisa kit
    In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and <t>(n)</t> <t>IFN-β</t> in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.
    Mouse Ifnβ Duoset Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse ifnβ duoset elisa kit/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    mouse ifnβ duoset elisa kit - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and (n) IFN-β in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.

    Journal: Materials Today Bio

    Article Title: Multiple-pathway cGAS-STING activation with enhanced mild photothermal therapy through glycolysis regulation for boosting gastric cancer immunotherapy

    doi: 10.1016/j.mtbio.2026.102790

    Figure Lengend Snippet: In vitro antitumor efficacy of the nanoparticles, ICD induction, and activation of the cGAS-STING pathway. Uptake of MOMn and MOMn@MB by MFC cells at (a) 4 and (b) 6 h. (c) Calcein-AM/PI and (d) JC-1 staining fluorescence images of MFC cells after treatment with different groups. Cytotoxicity analysis of MFC cells treated with (e) MO@MB and (f) MOMn@MB. Western blot analysis of (g) glycolysis pathway related proteins and (h) HSP70/90 in MFC cells treated with different nanoparticles. (i) CLSM images of CRT exposure on the surface of MFC cells after different treatments. (j) DNA damage assessment via γ-H2AX immunostaining in MFC cells treated with different nanoparticles. Levels of (k) lactate, (l) ATP, (m) HMGB1, and (n) IFN-β in MFC cells treated with different nanoparticles. (o) Western blot analysis of cGAS-STING pathway related proteins with different treatment. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.

    Article Snippet: The mouse HMGB1 enzyme-linked immunosorbent assay (ELISA) kit and mouse interferon-β (IFN-β) ELISA kit were purchased from Wuhan Elabscience Biotechnology Co., Ltd.

    Techniques: In Vitro, Activation Assay, Staining, Fluorescence, Western Blot, Immunostaining, Control

    DC maturation and activation of the cGAS-STING pathway. (a) Schematic diagram of the extraction from BMDCs to DC maturation and the Transwell assay. Created by Biorender. (b) Expression of CD80 and CD86 quantitatively determined by flow cytometry analysis with different treatments, and (c) the average DC maturation rate based on the results. (d) The levels of IFN-β in DC cells with different treatments. (e) Western blot analysis was employed to evaluate the expression of cGAS-STING pathway-related proteins in DC cells across different treatments. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.

    Journal: Materials Today Bio

    Article Title: Multiple-pathway cGAS-STING activation with enhanced mild photothermal therapy through glycolysis regulation for boosting gastric cancer immunotherapy

    doi: 10.1016/j.mtbio.2026.102790

    Figure Lengend Snippet: DC maturation and activation of the cGAS-STING pathway. (a) Schematic diagram of the extraction from BMDCs to DC maturation and the Transwell assay. Created by Biorender. (b) Expression of CD80 and CD86 quantitatively determined by flow cytometry analysis with different treatments, and (c) the average DC maturation rate based on the results. (d) The levels of IFN-β in DC cells with different treatments. (e) Western blot analysis was employed to evaluate the expression of cGAS-STING pathway-related proteins in DC cells across different treatments. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001. G1-G6 are denoted as Control, NIR Laser, MO@MB, MO@MB + NIR Laser, MOMn@MB, and MOMn@MB + NIR Laser groups, respectively.

    Article Snippet: The mouse HMGB1 enzyme-linked immunosorbent assay (ELISA) kit and mouse interferon-β (IFN-β) ELISA kit were purchased from Wuhan Elabscience Biotechnology Co., Ltd.

    Techniques: Activation Assay, Extraction, Transwell Assay, Expressing, Flow Cytometry, Western Blot, Control